Selen Güler

Selen Güler

Auto-generated profile, based on publicly available information

Selen Güler

Department of Pediatric Gastroenterology, Hepatology and Nutrition, İzmir Katip Çelebi University Faculty of Medicine, İzmir City Hospital, İzmir, Türkiye

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
BABetül Aksoy
Betül Aksoy
YAYeliz Çağan Appak
Yeliz Çağan Appak
MAMurat Akşit
Murat Akşit
SÇSerenay Çetinoğlu
Serenay Çetinoğlu
SKSinem KAHVECİ
Sinem KAHVECİ
MBMasallah Baran
Masallah Baran
Background: Leucine rich α-2 glycoprotein (LRG) is a glycoprotein that is an acute-phase protein produced by neutrophils, macrophages, hepatocytes, and intestinal epithelial cells. This study aimed to determine the serum LRG (s-LRG) and urine LRG (u-LRG) expression levels in children with inflammatory bowel disease (IBD) and evaluated their correlation with clinical disease activity, other inflammatory markers, laboratory results, and endoscopic activity scoring. Methods: This prospective observational study was conducted at a tertiary centre and included children aged 2–18 years with IBD. Clinic activity scoring was used to assess clinical disease activity. Haemoglobin levels, platelet counts, albumin, C-reactive protein, and erythrocyte sedimentation rate were analysed in the blood sample. LRG levels were measured in both blood and urine samples. The endoscopic assessment was scored according to the simple endoscopic score and Mayo endoscopic score. Serum and urine LRG levels were measured using commercial enzyme-linked immunosorbent assay kits. Disease activation was defined based on clinical activity scoring, laboratory results, and endoscopic evaluation. The results were compared between the active IBD and remission groups. Results: Forty-two (50%) patients with active IBD and forty-two (50%) patients in remission were included in this study. The serum levels of LRG were elevated in the patients with active IBD compared with the levels in the patients with IBD in remission (p = 0.020). However, there was no difference in the u-LRG level between the two groups (p = 0.407). In patients with IBD, positive correlations were observed between s-LRG, platelet count, C-reactive protein (CRP), and the erythrocyte sedimentation rate. The serum LRG was negatively correlated with albumin and haemoglobin levels. Urine LRG was not correlated with s-LRG in any patients with IBD included or in patients with active IBD. The cutoff value for s- LRG (77.03 μg/mL) had a sensitivity and specificity of 40.4% (95% CI 25.6–56.7%) and 88.1% (95% CI 74.3–96.0%), respectively. It was found that s-LRG was a more significant parameter than CRP in predicting disease activation. Conclusions: This prospective study demonstrated that the s-LRG level is a useful biomarker for predicting disease activation in children with IBD and appears to be a more significant parameter than the CRP level. However, the u-LRG level is not effective in predicting disease activation in children with IBD.

15 September 2023 in Turkish Journal of Gastroenterology
Verified
Journal Article
Open access
SGSelen Güler
Selen Güler
BABetül Aksoy
Betül Aksoy
MÖM. Onur Öztan
M. Onur Öztan
YAYeliz Çağan Appak
Yeliz Çağan Appak
SKSinem KAHVECİ
Sinem KAHVECİ
MBMasallah Baran
Masallah Baran
Background/Aims: Achalasia is a primary motility disorder characterized by a relaxation disorder of the lower esophageal sphincter. In pneumatic balloon dilatation, which is one of the treatment methods, the muscle fibers are torn with an endoscopically inflated balloon in the lower esophageal sphincter. This study aimed to evaluate the results of long-term pneumatic balloon dilatation treatment in our clinic for children diagnosed with achalasia. Materials and Methods: Pediatric patients who underwent pneumatic balloon dilatation with a diagnosis of achalasia in our pediatric gastroenterology clinic between 2016 and 2021 were included in the study. Demographic data of the patients, clinical findings at diagnosis, and follow-up results were evaluated retrospectively. Results: Ten patients who underwent 18 pneumatic balloon dilatation operations were included in the study. The mean follow-up period of the patients was 23.7 ± 14.1 months. It was observed that the procedure was performed once in 3 (30%) patients, twice in 2 (20%) patients, and 3 times in 3 (30%) patients. It is noteworthy that the diameter of the balloon used in the first procedure in patients who needed repeated operations was less than 30 mm. No complications were observed except for chest pain, which was detected in 1 patient. Conclusion: When the patients who needed recurrent dilatation were evaluated, it was noted that the diameter of the balloon in which the first procedure was performed in these patients was smaller. This study is an important contribution to the literature due to the scarcity of the pediatric achalasia data, in which long-term results related to pneumatic balloon dilatation are reported in Turkey. Cite this article as: Güler S, Aksoy B, Öztan MO, et al. The results of pneumatic balloon dilatation treatment in children with achalasia: A single-center experience. Turk J Gastroenterol. 2023;34(9):968-974.

10 December 2025 in Medicina
Verified
Journal Article
Open access
PDF file
BABetül Aksoy
Betül Aksoy
ŞKŞenay Onbaşı Karabağ
Şenay Onbaşı Karabağ
YAYeliz Çağan Appak
Yeliz Çağan Appak
SGSelen Güler
Selen Güler
SKSinem KAHVECİ
Sinem KAHVECİ
MBMasallah Baran
Masallah Baran
Background and Objectives: Catheter-related bloodstream infections (CRBSIs) are one of the most severe complications in children with intestinal failure (IF) who require long-term parenteral nutrition (PN). Taurolidine–citrate solution (TCS), with proven antimicrobial and antibiofilm properties, has been proposed as a promising alternative to heparin locks for preventing infection. The aim is to evaluate the efficacy and safety of the TCS in reducing the rates of CRBSI and pathogen-specific infections in pediatric patients with indwelling central venous catheters (CVCs) who are receiving PN. Materials and Methods: This retrospective study included 48 pediatric IF patients treated at an intestinal rehabilitation and transplantation center in Türkiye. Patients received either TCS or heparinized saline (0.9% saline solution containing 100 IU of heparin) as a catheter lock. Infection data were extracted from medical records and expressed as events per 1000 catheter days. Group comparisons were performed using non-parametric tests, and Poisson regression was applied to calculate rate ratios (RRs) and 95% confidence intervals (CIs). Adjusted rate ratios were obtained from a Poisson regression model that included the following variables: age, sex, diagnosis category, ostomy status, catheter type, and follow-up duration. Log(catheter-days) was incorporated as an offset term. Overdispersion was assessed and not detected. Results: The crude CRBSI rate was lower in the TCS group than in the heparinized saline group (29.4 vs. 42.8 per 1000 catheter days), though this difference was not statistically significant (p = 0.383). However, after adjustment by Poisson regression, TCS use was significantly associated with reduced infection rates (adjusted RR = 0.78, 95% CI = 0.70–0.87, p < 0.001). TCS use was also significantly associated with reduced rates of Gram-positive (RR = 0.78, p = 0.006), Gram-negative (RR = 0.48, p < 0.001) and fungal (RR = 0.63, p < 0.001) infections. No adverse events were observed among the TCS group. Conclusions: Standardized TCS lock therapy effectively and safely reduces CRBSIs in pediatric patients with IF, particularly those caused by Gram-negative and fungal organisms. These results support the use of TCS as a prophylactic option for preventing infection in long-term CVC use.

1 June 2022 in Turkish Journal of Gastroenterology
Verified
Journal Article
Closed access
ŞKŞenay Onbaşı Karabağ
Şenay Onbaşı Karabağ
MBMasallah Baran
Masallah Baran
BABetül Aksoy
Betül Aksoy
YAYeliz Çağan Appak
Yeliz Çağan Appak
SKSinem KAHVECİ
Sinem KAHVECİ
DÇDilek Yılmaz Çiftdoğan
Dilek Yılmaz Çiftdoğan
Background: Given that procedures involving gastrointestinal tract lumens are high-risk and aerosol forming, the functioning of endos- copy units has been reorganized during the coronavirus disease 2019 pandemic. Guidelines recommend that all personnel should carry out procedures in a negative-pressure room with personal protective equipment; in the absence of a negative-pressure room, an ade- quately ventilated room should be used. During the normalization of the coronavirus disease 2019 pandemic, this study aimed to evalu- ate children who were treated in our endoscopy unit without a negative-pressure chamber in terms of coronavirus disease 2019 after procedures. Methods: Patients were questioned and evaluated prospectively for symptoms and contact with coronavirus disease 2019 patients on before and 7th and 14th days after the procedure. Results: Seventy-eight procedures were performed on 69 patients over a 3-month period. The mean age of patients was 12.0 ± 5.1 years. Among all the procedures performed, 54 (69.2%) involved upper gastrointestinal system (GIS) endoscopy and 24 (30.8%) involved colo- noscopy. Furthermore, 72 (91.3%) of the procedures were performed in the pediatric endoscopy unit, and 6 (7.7%) were performed in the operating room. No coronavirus disease 2019 symptoms or presence was detected in the patients. Conclusion: The ideal setting for an endoscopic procedure is in a negative-pressure chamber. However, this study has shown that endoscopic procedures can be performed in units without negative-pressure rooms but with appropriate protective equipment and evaluation of patients for coronavirus disease 2019 symptoms. Cite this article as: Onbaşı Karabağ S, Baran M, Aksoy B, et al. Evaluation of children undergoing endoscopic procedures during the normalization of the coronavirus disease 2019 pandemic. Turk J Gastroenterol. 2022;33(6):515-519.

11 March 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
BABetül Aksoy
Betül Aksoy
YAYeliz Çağan Appak
Yeliz Çağan Appak
MAMurat Akşit
Murat Akşit
SÇSerenay Çetinoğlu
Serenay Çetinoğlu
SKSinem KAHVECİ
Sinem KAHVECİ
MBMasallah Baran
Masallah Baran
Background: Leucine rich α-2 glycoprotein (LRG) is a 50 kDa glycoprotein that is an acute-phase protein produced by neutrophils, macrophages, hepatocytes, and intestinal epithelial cells. This study aimed to determine the serum LRG (s-LRG) and urine LRG (u-LRG) expression levels in children with inflammatory bowel disease (IBD) and evaluated their correlation with clinical disease activity, other inflammatory markers, laboratory results, and endoscopic activity scoring. Methods: This prospective observational study was conducted at a tertier centre and included children with IBD . Disease activation was defined based on clinical activity scoring, laboratory results, and endoscopic evaluation. Serum and urine LRG levels were measured via commercial enzyme-linked immunosorbent assay kits. The results were compared between the active IBD and remission groups. Results: Forty-two (50%) patients with active IBD and 42 (50%) patients in remission, were included in this study. Serum LRG concentrations were elevated in the active IBD patients compared with those in IBD patients in remission (p = 0.020). However, there was no difference in the u-LRG level between the two groups (p = 0.407). In patients with IBD, positive correlations were observed between s-LRG, platelet count, C-reactive protein (CRP), and the erythrocyte sedimentation rate . The serum LRG was negative correlated with albumin and hemoglobin levels. Urine LRG was not correlated with s-LRG in any IBD patients included or in IBD patients with active IBD. The cutoff value for s- LRG (77.03 μg/mL) had sensitivity and specificity of 40.4% (95% CI 25.6–56.7%) and 88.1% (95% CI 74.3–96.0%), respectively. It was found that s-LRG was a more significant parameter than CRP in predicting disease activation. Conclusion: This prospective study demonstrated that the s-LRG level is a useful biomarker for predicting disease activation in children with IBD and appears to be a more significant parameter than the CRP level. However, the u-LRG level is not effective in predicting disease activation in children with IBD.

12 June 2023 in Journal of Pediatric Infectious Diseases
Verified
Journal Article
Closed access
PDF file
SGSelen Güler
Selen Güler
BABetül Aksoy
Betül Aksoy
YAYeliz Çağan Appak
Yeliz Çağan Appak
SKSinem KAHVECİ
Sinem KAHVECİ
ŞKŞenay O. Karabağ
Şenay O. Karabağ
MBMasallah Baran
Masallah Baran
Objective Inflammatory bowel disease is a chronic inflammatory disease of the gastrointestinal tract. Some difficulties and differences were experienced during the coronavirus disease 2019 (COVID-19) pandemic period for monitoring of chronic diseases. In this study, the effect of the COVID-19 pandemic on the frequency and course of inflammatory bowel disease in children was evaluated. Methods The first severe acute respiratory syndrome coronavirus 2 case in Türkiye was diagnosed on March 11, 2020. The pandemic period was defined as the year following this date, and the pre-pandemic period as the preceding year. The number of patients newly diagnosed with inflammatory bowel disease and their clinical presentations during the pandemic period and pre-pandemic period was compared. In addition, the clinical features of previously diagnosed inflammatory bowel disease patients in the pandemic period and pre-pandemic period were compared. Results Eighty-six patients in a pediatric gastroenterology clinic between 2009 and 2021 were included. The number of newly diagnosed patients was higher during the pandemic period (n = 14) compared with the pre-pandemic period (n = 18; p = 0.017). Fifty-four patients were follow-up patients diagnosed before 2019: the mean number of outpatient clinic visits, disease attacks, and hospitalizations was lower pandemic period than pre-pandemic period (p < 0.01). Conclusion The changes experienced during pandemic period may have triggered more cases of inflammatory bowel disease. However, we found no evidence that either less face-to-face follow-up of, or life changes in, existing inflammatory bowel disease patients during the pandemic period adversely affected their clinical outcomes.